The Biocidal Products Regulation is applicable to all the Member States of the EU. The competent authority in the matter is the European Chemical Agency (ECHA); they explain the regulation as follows:
"The Biocidal Products Regulation (BPR, Regulation (EU) 528/2012) concerns the placing on the market and use of biocidal products, which are used to protect humans, animals, materials or articles against harmful organisms like pests or bacteria and fungi, by the action of the active substances contained in the biocidal product. This regulation aims to improve the harmonization of the biocidal products market in the EU, while ensuring a high level of protection for human, animals and the environment.
All biocidal products require an authorisation before they can be placed on the market, and the active substance(s) contained in that biocidal product must be previously approved on European level. There are, however, certain exceptions to this principle. For example, biocidal products containing active substance(s) in the Review Programme can be made available on the market and used (subject to national laws) pending the final decision on the approval of the active substance(s). Products containing new active substances that are still under assessment may also be allowed on the market where a provisional authorisation is granted.
The BPR aims to harmonise the market at European level; to simplify the approval of active substances and authorisation of biocidal products; and introduce timelines for Member State evaluations, opinion-forming and decision-making. It also promotes the reduction of animal testing by introducing mandatory data sharing obligations and encouraging the use of alternative testing methods.
The approval of active substances takes place at European level and the subsequent authorisation of the biocidal products at Member State level. This authorisation can be extended to other Member States by mutual recognition. However, the new regulation also provides applicants with the possibility of a new type of authorisation at Union level (Union authorisation).
A dedicated IT platform, the Register for Biocidal Products (R4BP 3), needs to be used for submitting applications, exchanging data and information between the applicant, ECHA, Member States competent authorities and the European Commission. Another IT tool, IUCLID, is used for preparing the applications."
See ECHA's website.